SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cellsHanjun Zhao, Kelvin Kai‐Wang To, Chuyuan Zhang et al.|Emerging Microbes & Infections|2021Cited by 474
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2Hanjun Zhao, Kwok‐Yung Yuen, Jinxia Zhang et al.|Nature Communications|2021Cited by 61